<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lymphomatous diseases (non-Hodgkin's) of children differ markedly from those of adults in histology, natural history, and response to therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Information obtained from treating adults with <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cannot be applied to children with equal success; the progress in treating children has been slow </plain></SENT>
<SENT sid="2" pm="."><plain>The following types of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> have been distinguished in children seen at the M </plain></SENT>
<SENT sid="3" pm="."><plain>D </plain></SENT>
<SENT sid="4" pm="."><plain>Anderson Hospital and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> Institute in the past 7 years: 1) diffuse undifferentiated <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>); 2) diffuse undifferentiated <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (non-Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> lacking leukemic propensity); 3) diffuse poorly differentiated lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (non-Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with leukemic propensity (convoluted cell type); and 4) diffuse histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) </plain></SENT>
<SENT sid="5" pm="."><plain>The interrelationships of age, sex, histology, and primary site are presented </plain></SENT>
<SENT sid="6" pm="."><plain>The occurrence of mediastinal masses in non-<z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt's tumor</z:e> (convoluted cell type) is particularly striking </plain></SENT>
<SENT sid="7" pm="."><plain>Therapeutic regimens designed for specific types of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> have improved the outcome of treatment in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, non-Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (convoluted cell type), and histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (Stages I and II) as compared with treatment regimens used prior to 1967 </plain></SENT>
</text></document>